• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by 908 Devices Inc.

    4/28/25 9:03:24 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials
    Get the next $MASS alert in real time by email
    DEFA14A 1 tm252434d3_defa14a.htm DEFA14A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a) of

    the Securities Exchange Act of 1934

    (Amendment No.            )

     

    Filed by the Registrant x

     

    Filed by a Party other than the Registrant ¨

     

    Check the appropriate box:

     

    ¨ Preliminary Proxy Statement
       
    ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
       
    ¨ Definitive Proxy Statement
       
    x Definitive Additional Materials
       
    ¨ Soliciting Material under §240.14a-12

     

    908 DEVICES INC.

    (Name of Registrant as Specified In Its Charter)

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    xNo fee required.

     

    ¨Fee paid previously with preliminary materials.

     

    ¨Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     

     

     

     

     

    GRAPHIC

    Step 1: Go to www.envisionreports.com/MASS. Step 2: Click on Cast Your Vote or Request Materials. Step 3: Follow the instructions on the screen to log in. www.envisionreports.com/MASS Online Go to www.envisionreports.com/MASS or scan the QR code — login details are located in the shaded bar below. Stockholder Meeting Notice 0454JA Important Notice Regarding the Availability of Proxy Materials for 908 Devices Inc. Stockholder Meeting to be Held on June 12, 2025. Under Securities and Exchange Commission rules, you are receiving this notice that the proxy materials for the annual stockholders’ meeting are available on the Internet. Follow the instructions below to view the materials and vote online or request a copy. The items to be voted on and location of the annual meeting are on the reverse side. Your vote is important! This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The 2025 Proxy Statement and 2024 Annual Report on Form 10-K to shareholders are available at: Obtaining a Copy of the Proxy Materials – If you want to receive a copy of the proxy materials, you must request one. There is no charge to you for requesting a copy. Please make your request as instructed on the reverse side on or before May 28, 2025 to facilitate timely delivery. 2NOT Easy Online Access — View your proxy materials and vote. When you go online, you can also help the environment by consenting to receive electronic delivery of future materials. Step 4: Make your selections as instructed on each screen for your delivery preferences. Step 5: Vote your shares.

    GRAPHIC

    Here’s how to order a copy of the proxy materials and select delivery preferences: Current and future delivery requests can be submitted using the options below. If you request an email copy, you will receive an email with a link to the current meeting materials. PLEASE NOTE: You must use the number in the shaded bar on the reverse side when requesting a copy of the proxy materials. — Internet – Go to www.envisionreports.com/MASS. Click Cast Your Vote or Request Materials. — Phone – Call us free of charge at 1-866-641-4276. — Email – Send an email to [email protected] with “Proxy Materials 908 Devices” in the subject line. Include your full name and address, plus the number located in the shaded bar on the reverse side, and state that you want a paper copy of the meeting materials. To facilitate timely delivery, all requests for a paper copy of proxy materials must be received by May 28, 2025. 908 Devices Inc. 2025 Annual Meeting of Stockholders will be held on June 12, 2025, at 10:00 a.m. Eastern Time, virtually via the internet at meetnow.global/M5UTCGT. To access the virtual meeting, you must have the information that is printed in the shaded bar located on the reverse side of this form. Proposals to be voted on at the meeting are listed below along with the Board of Directors’ recommendations. The Board of Directors recommend a vote FOR all the nominees listed and FOR Proposal 2: 1. To elect three Class II directors to hold office until the 2028 annual meeting of stockholders. 01 - Kevin J. Knopp, Ph.D. 02 - Tony J. Hunt 03 - Mark Spoto 2. To ratify, on an advisory basis, the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. 3. To transact any other business that properly comes before the Annual Meeting and at any adjournments and postponements thereof. PLEASE NOTE – YOU CANNOT VOTE BY RETURNING THIS NOTICE. To vote your shares you must go online or request a paper copy of the proxy materials to receive a proxy card. Stockholder Meeting Notice

    Get the next $MASS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MASS

    DatePrice TargetRatingAnalyst
    8/5/2025$12.00Market Perform → Outperform
    Leerink Partners
    11/13/2024$12.00 → $4.00Outperform → Market Perform
    Leerink Partners
    2/7/2023$14.00Overweight
    Stephens
    3/8/2022$40.00 → $30.00Outperform
    SVB Leerink
    10/15/2021Outperform
    Cowen
    More analyst ratings

    $MASS
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by 908 Devices Inc.

    SCHEDULE 13G - 908 Devices Inc. (0001555279) (Subject)

    2/9/26 6:14:22 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - 908 Devices Inc. (0001555279) (Filer)

    1/20/26 7:15:12 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by 908 Devices Inc.

    SCHEDULE 13G/A - 908 Devices Inc. (0001555279) (Subject)

    12/5/25 4:32:08 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Knopp Kevin J. bought $66,596 worth of shares (15,000 units at $4.44), increasing direct ownership by 2% to 722,733 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    5/19/25 4:37:42 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Director Spoto Mark bought $42,850 worth of shares (10,000 units at $4.29), increasing direct ownership by 19% to 62,971 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    5/15/25 4:52:08 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    President and CEO Knopp Kevin J. bought $64,788 worth of shares (15,000 units at $4.32), increasing direct ownership by 2% to 707,733 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    5/14/25 4:28:02 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Griffith Joseph H. Iv converted options into 70,141 shares and sold $143,222 worth of shares (23,175 units at $6.18), increasing direct ownership by 51% to 139,896 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    2/3/26 8:45:22 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    President and CEO Knopp Kevin J. converted options into 107,999 shares and sold $214,842 worth of shares (34,764 units at $6.18), increasing direct ownership by 10% to 795,968 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    2/3/26 8:45:24 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Director Spoto Mark gifted 928 shares, received a gift of 928 shares and transferred by will 928 shares), increasing direct ownership by 1% to 75,263 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    2/3/26 8:45:21 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    908 Devices upgraded by Leerink Partners with a new price target

    Leerink Partners upgraded 908 Devices from Market Perform to Outperform and set a new price target of $12.00

    8/5/25 1:46:38 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices downgraded by Leerink Partners with a new price target

    Leerink Partners downgraded 908 Devices from Outperform to Market Perform and set a new price target of $4.00 from $12.00 previously

    11/13/24 8:05:47 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Stephens initiated coverage on 908 Devices with a new price target

    Stephens initiated coverage of 908 Devices with a rating of Overweight and set a new price target of $14.00

    2/7/23 6:37:28 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    908 Devices Enhances MX908 Usability and Adds New Drug Targets

    New mission mode provides simpler and more intuitive sampling of hazardous vapors 908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces new capabilities for its handheld MX908 mass spectrometry device for trace chemical identification. These enhancements include an updated mission mode for hazardous vapor sampling and the addition of five priority drug targets, providing first responders with intelligence at the point of need for an informed, confident response. The MX908 mission modes, which include Drug Hunter, Explosives Hunter, and CW (chemical warfare) Hunter, have matured into the most powerful and complete capabilities in the

    2/5/26 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025

    Preliminary full year 2025 revenue of approximately $56 million, representing ~17% growth year-over-year Achieved positive Adjusted EBITDA goal in the fourth quarter 908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced preliminary unaudited financial results for the quarter and full year ended December 31, 2025. Preliminary unaudited revenue for the fourth quarter of 2025 is approximately $17.2 million, compared to $14.3 million in the fourth quarter of 2024, reflecting reported growth of approximately 20%. Fourth quarter strength was driven by c

    1/20/26 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

    Year-to-date revenue increased 16% while Adjusted EBITDA loss improves 53% quarter over quarter 908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended September 30, 2025. "We are pleased with our year-to-date progress as we continue to build a more predictable and profitable business and bring our 908 Devices 2.0 vision to life," said Kevin J. Knopp, CEO and Co-founder. "Revenue for the first nine months increased 16%, with strong FTIR demand and with 47% of revenues coming from our U.S. state and local channel. T

    11/10/25 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 908 Devices Inc.

    SC 13G/A - 908 Devices Inc. (0001555279) (Subject)

    11/14/24 5:11:18 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by 908 Devices Inc.

    SC 13G/A - 908 Devices Inc. (0001555279) (Subject)

    11/14/24 4:25:10 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by 908 Devices Inc.

    SC 13G/A - 908 Devices Inc. (0001555279) (Subject)

    7/8/24 4:32:41 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Financials

    Live finance-specific insights

    View All

    908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

    Year-to-date revenue increased 16% while Adjusted EBITDA loss improves 53% quarter over quarter 908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended September 30, 2025. "We are pleased with our year-to-date progress as we continue to build a more predictable and profitable business and bring our 908 Devices 2.0 vision to life," said Kevin J. Knopp, CEO and Co-founder. "Revenue for the first nine months increased 16%, with strong FTIR demand and with 47% of revenues coming from our U.S. state and local channel. T

    11/10/25 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025

    908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will report financial results for the third quarter 2025 before market open on Monday, November 10, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available on the "Investors" section of the company website at: www.908devices.com. The webcast will be archived and available for replay within 24 hours after the event. About 908 Devices 908 Devices is revolutionizing chemical ana

    10/22/25 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook

    Revenue from continuing operations grew 14% compared to prior year 908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended June 30, 2025. "We executed with urgency and discipline in the second quarter, driving strong top-line growth while advancing key structural initiatives to strengthen our financial profile," said Kevin J. Knopp, CEO and Co-founder. "We delivered record XplorIR placements, successfully launched VipIR, and made meaningful progress on our path to profitability. These achievements reinforce our c

    8/5/25 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Leadership Updates

    Live Leadership Updates

    View All

    908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors

    908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Dr. Brandi Vann to serve on its Board of Directors. During more than 15 years at the U.S. Department of Defense (DoD), Dr. Vann held several leadership positions overseeing nuclear, chemical, and biological defense programs. The company also announces that Jeff George, a veteran biopharma leader, has stepped down from its Board of Directors due to the company's strategic refocus on public health, safety and defense tech. These changes are effective immediately. Previously, Dr. Vann was Performing the Duties of the Assistant Secretary of Defense for Nuclear, Ch

    8/4/25 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices Appoints Christopher D. Brown to its Board of Directors

    908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead

    6/16/25 8:00:00 AM ET
    $AAPL
    $MASS
    $RGEN
    Computer Manufacturing
    Technology
    Industrial Machinery/Components
    Industrials

    908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors

    908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, has appointed Michele M. Leonhart, the former Administrator of the United States Drug Enforcement Administration (DEA), to serve on its Board of Directors effective immediately. Ms. Leonhart brings a deep understanding of our customers in law enforcement and adjacent markets. Her 34-year career in the DEA encompassed various positions with increasing levels of responsibility, including Special Agent in Charge of the Los Angeles Field Division from 1998 to 2003, Deputy Administrator (nominated by President Bush) from 2003 to 2007, Acting Administrator from 2007 to 2010, and Admini

    6/25/24 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials